Evaluation of Microwave Ablation in 4T1 Breast Tumor by a Novel VEFGR2 Targeted Ultrasound Contrast Agents
ObjectivesA novel ultrasound contrast agent (UCA) VEGFR2-targeting iron-doped silica (SiO2) hollow nanoparticles (VEGFR2-PEG-HSNs-Fe NPs) was prepared and applied in microwave ablation for breast cancer to investigate its value in the evaluation of effectiveness after tumor ablation.MethodsVEGFR2-PE...
Main Authors: | Xiaoyu Li, Shujun Xia, Ri Ji, Weiwei Zhan, Wei Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.690152/full |
Similar Items
-
Comparison of the efficacy and safety of ultrasound-guided radiofrequency ablation and microwave ablation for the treatment of unifocal papillary thyroid microcarcinoma: a retrospective study
by: Ning Li, et al.
Published: (2024-12-01) -
Value of contrast-enhanced ultrasonography in microwave ablation treatment of symptomatic focal uterine adenomyosis
by: Xiao-Long Li, et al.
Published: (2024-01-01) -
Combined transabdominal and transvaginal ultrasound-guided percutaneous microwave ablation of uterine myomas: an effective monitoring technique
by: Min Lin, et al.
Published: (2023-12-01) -
Application of contrast-enhanced ultrasound in minimally invasive ablation of benign thyroid nodules
by: Jiaying Cao, et al.
Published: (2022-02-01) -
Contrast-enhanced ultrasound and microwave ablation of Epstein–Barr virus associated smooth muscle tumors in a patient with AIDS: a case report
by: Yuanping Yang, et al.
Published: (2024-09-01)